Compounds for inhibiting KSP kinesin activity
US8796460B2 · kind B2 · utility
0Cited by
0References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2008 |
| Grant date | Aug 5, 2014 |
| Priority date | — |
| Expiry date | Jul 9, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D515/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula (I), below, (wherein X, R1, R2, R3, p, E, ring A, and ring B are as defined herein). The present invention also relates to compositions (including pharmaceutically acceptable compositions) comprising these compounds, alone and in combination with one or more additional therapeutic agents, and to methods for their use in inhibiting KSP kinesin activity, and for treating cellular proliferative diseases or disorders associated with KSP kinesin activity. Formula I
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.